Wigmore_Amy

Amy Kreiger Wigmore

Partner

  • Co-Chair, Intellectual Property Litigation Practice Group

Amy Wigmore is a first-chair trial lawyer with more than 20 years of experience managing complex litigation, focusing primarily on technology disputes. She is a member of the firm's Litigation/Controversy Department and Intellectual Property Litigation Practice.

Ms. Wigmore is widely known for her trial work. She is a fellow of the Litigation Counsel of America, and she has been recognized as a leading IP Litigation practitioner by several publications, including Chambers, LMG Life Sciences, and Managing IP.

Ms. Wigmore has extensive experience representing clients in the pharmaceutical, biotechnology and medical device industries. She has participated in several jury trials and secured multiple verdicts exceeding $500 million on behalf of her clients. Ms. Wigmore also has played a leading role in bench trials, arbitrations and appellate matters.

In addition to her patent litigation experience, Ms. Wigmore has represented clients in cases involving the misappropriation of trade secrets, unfair competition, breach of contract, employment disputes, civil rights claims and test security issues.

 
  • Amy Wigmore Recognized Among Nation's Best for Intellectual Property Litigation

    Chambers USA announced its rankings for the 2021 edition and named Partner Amy Wigmore as a leader in her field.

    May 20, 2021
    Read More
  • Amy Wigmore Named Among the Top 250 Women in IP

    Managing Intellectual Property's 2018 IP Stars Handbook recognizes Partner Amy Wigmore for her knowledge, outcomes achieved for clients and unique strengths in her given practice area.

    May 17, 2018
    Read More

Experience

    • Achieved complete victory for pharmaceutical clients at trial and on appeal in a Hatch-Waxman case involving multiple generic challenges to patents covering a blockbuster drug.
    • Participated a jury trial resulting in a $539 million damages award for a technology client.
    • Represent pharmaceutical company in defending against a challenge to patents covering a blockbuster oncology drug.
    • Represent biotechnology company in multiple appeals concerning patents relating to vaccine formulation.
    • Secured a victory for a pharmaceutical company in a jury trial on patent validity and obtained a $2.15 billion settlement for patent infringement damages resulting from an “at-risk” launch of a generic pharmaceutical product. 
    • Represented a biotechnology company in a highly successful five-year legal battle involving a licensing dispute with a major clinical diagnostics company. The 10-week jury trial resulted in a $505 million verdict for our client and ultimately led to a $1.4 billion acquisition of our client by the defendant. 
    • Represented a major pharmaceutical company in multiple jury trials, bench trials, and US and international arbitrations involving biotechnology patents. 
    • Achieved a favorable jury verdict for a medical device company in patent litigation concerning safety needles and blood collection devices.
    • Successfully argued on behalf of a pharmaceutical company for dismissal of patent infringement allegations concerning a biotechnology patent on the grounds that the asserted claims were unpatentable. 
    • Served as lead counsel for a power wheelchair manufacturer in defending against patent infringement allegations. 
    • Represented a medical device company in defending a patent infringement case involving surgical ablation devices. 
    • Successfully argued in the Federal Circuit for dismissal of the appeal of an inter partes reexam in which the patent claims asserted against a medical device manufacturer were found invalid. 
    • Represented a pharmaceutical company in the appeals of Hatch-Waxman cases involving treatments for Hepatitis C and HIV. 
    • Successfully represented a pharmaceutical company in a Hatch-Waxman patent infringement case involving a treatment for HIV. 
    • Served as lead counsel in a patent infringement case involving biotechnology. 
    • Served as lead counsel for the defendant in a patent infringement case concerning digital audio technology. 
    • Represented a pharmaceutical company in a license dispute concerning drug-eluting stents.
    • Successfully represented a pharmaceutical company in a Hatch-Waxman patent infringement case involving a treatment for Parkinson's disease.

Recognition

  • Award Text

    Top 250 Women in IP

    Managing IP

    2018, 2023-2024

  • Award Text

    Life Sciences Star for Intellectual Property

    LMG Life Sciences

    2016-2023

  • Award Text

    Leading Lawyer for Intellectual Property Litigation

    Chambers USA

    2017-2024

  • Recognized by the American Lawyer's Litigation Daily as a Litigator of the Week Runner-Up in 2024.
  • Recognized in 2022–2024 as a leading practitioner in patent law (litigation) by IAM Patent 1000: The World's Leading Patent Practitioners.  
  • Named 2021 Patent Litigation Practitioner of the Year for the DC metro area by Managing IP.
  • Regularly recognized by Chambers USA Guide in Washington DC for intellectual property litigation.
  • Honored with the 2019 Women Worth Watching Award from Profiles in Diversity Journal.
  • Fellow, Litigation Counsel of America.
  • Recommended in the 2016 and 2017 editions of The Legal 500 United States for healthcare: life sciences and intellectual property: patents: prosecution.
  • Shortlisted in the “General Patent Litigator of the Year – District of Columbia” category in 2018, 2019, and 2024, and to the 2017 awards shortlist for Hatch-Waxman Litigator of the Year: Branded by LMG Life Sciences. Also named a "Life Sciences Star" in 2016–2023 for intellectual property.
  • Recognized in 2013–2024 as a leader in her field and an IP Star by Managing IP and consistently featured in its accompanying Top 250 Women in IP list.
  • Named a leading lawyer for intellectual property litigation in the 2020 and 2021 editions of Washington DC Super Lawyers.
  • Named to the Lawdragon 500 Leading Litigators in America list.
 

Insights & News

Credentials

  • Education

    • JD, Harvard Law School, 1995

      magna cum laude
    • BA, University of Massachusetts, 1992

      Phi Beta Kappa
  • Admissions

    • District of Columbia

    • Massachusetts

    • US Supreme Court

    • US Court of Appeals for the District of Columbia Circuit

    • US Court of Appeals for the Federal Circuit

    • US Court of Appeals for the Sixth Circuit

    • US District Court for the District of Colorado

    • US District Court for the District of Columbia

    • US District Court for the District of Massachusetts

Credentials

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.